It is currently Sun Aug 02, 2015 3:43 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Site registration problems

We are currently experiencing problems with our email system sending out activation emails. If you have tried to register, but didn't receive the account activation email, then please contact us at timshelp@yahoo.com or click on the 'Contact Us' link at the bottom of the page.
Read more : Site registration problems | Views : 220 | Replies : 0 | Forum : General Discussion


Site registration problems

We are currently experiencing problems with our email system sending out activation emails. If you have tried to register, but didn't receive the account activation email, then please contact us at timshelp@yahoo.com or click on the 'Contact Us' link at the bottom of the page.
Read more : Site registration problems | Views : 118 | Replies : 0 | Forum : Site Support


Identifying MS gene mutations could lead to personalised....

Identifying MS gene mutations could lead to personalised treatments

Personalised medicine, often applied to treat cancer, may be possible for patients with multiple sclerosis as well. Certain patients respond differently to certain multiple sclerosis medications, such as interferon-β (IFNβ), and researchers at San Raffaele Scientific Institute in Milan may have an answer as to why.... Read More - http://www.ms-uk.org/genetics
Read more : Identifying MS gene mutations could lead to personalised.... | Views : 198 | Replies : 0 | Forum : Gene Therapy


OCT supported in monitoring Multiple Sclerosis

Rates of ganglion cell + inner plexiform layer (GCIP) atrophy mirrors that of whole brain atrophy in multiple sclerosis (MS), as measured by optimal coherence tomography (OCT), according to a study published in the Annals of Neurology.... Read More - http://www.ms-uk.org/medicalimaging
Read more : OCT supported in monitoring Multiple Sclerosis | Views : 160 | Replies : 0 | Forum : General Discussion


New Here. Could Use Some Help

Hey all. Like many here, I'm wondering about the possibility that I may have MS. I'm aware that there's a lot of anxious scared people like me that come on here begging for answers and I know I shouldn't expect any answers nor a diagnosis of any sort. With that said, I'd still like your guys' honest opinions. I'll keep my background/story short. For awhile now I've been experiencing what I'd say are "neuropsychiatric" symptoms. ...
Read more : New Here. Could Use Some Help | Views : 182 | Replies : 3 | Forum : Undiagnosed


Anxiety 'linked to gender in multiple sclerosis'

Researchers in Canada have been investigating what role gender has to play in patients with MS having anxiety and depression.... Read More - http://www.ms-uk.org/mssymptomsresearch
Read more : Anxiety 'linked to gender in multiple sclerosis' | Views : 242 | Replies : 0 | Forum : General Discussion


Lesion location 'matters in Multiple Sclerosis'

An observational clinical imaging study is claiming that cortical lesions (CLs) are associated with cognitive and physical disability in multiple sclerosis (MS), independent of white matter lesion volume... Read More - http://www.ms-uk.org/medicalimaging
Read more : Lesion location 'matters in Multiple Sclerosis' | Views : 237 | Replies : 0 | Forum : General Discussion


optic neuritis

Hi, I'm new here and new to thinking about MS.

Last week I was diagnosed with optic neuritis when I saw an optometrist for a routine exam. It's actually in both eyes (which I think is sort of uncommon) but worse in the left eye. The optometrist referred me to a neurologist who did a neurological exam and ordered blood work and several MRIs (cervical, brain, orbits). My cervical MRI was done last Friday and ...
Read more : optic neuritis | Views : 247 | Replies : 2 | Forum : Undiagnosed


Starts a dendritic cell trial adapted to MS

The Spanish Agency for Medicines and Health Products (AEMPS) has approved the first clinical trial of a specific antigen therapy based on dendritic cells adapted for patients with MS and NMO, (also called Devic's disease).

This research, which will be led by Pablo Villoslada and Daniel Benitez from the Clinic Hospital of Barcelona, is driven by the Grupo de Afectados de Esclerosis Múltiple (GAEM), and has the support of the Obra Social La Caixa.

The ...
Read more : Starts a dendritic cell trial adapted to MS | Views : 323 | Replies : 0 | Forum : Drug Pipeline


Firm focuses on venom-based paediatric MS treatment

Nutra Pharma, a US-based biotechnology company specialising in the acquisition, licensing, and commercialisation of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, has announced it has filed an application with the US Food and Drug Administration (FDA) for orphan drug status for its investigational drug RPI-78M as a treatment for paediatric multiple sclerosis (MS)..... Read More - http://www.ms-uk.org/emergingtherapies
Read more : Firm focuses on venom-based paediatric MS treatment | Views : 186 | Replies : 0 | Forum : General Discussion


 

Login  •  Register


Statistics

Total posts 226740 • Total topics 23883 • Total members 15157


Contact us | Terms of Service